Purchase Order HHSF223201610281A
Award Date
8/1/16
Potential Completion Date
7/31/17
Potential Value
$1.3M
Federal Agency
Food and Drug Administration
Awardee
Bruker Biospin Corp
Ultimate Awardee
Bruker Scientific LLC
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Jamaica, NY 11433, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $93,143.40 fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for a Bruker Avance III 500 MHz NMR service contract. The contract has a period of performance through September 16, 2021 and is not associated with a larger contract vehicle or set-aside designation. Bruker Biospin Corp is a provider of nuclear magnetic resonance (NMR) spectrometers, maintenance, and support services to...
This is a $159,767.50 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for the provision of a Bruker Avance III 500 MHz Nuclear Magnetic Resonance (NMR) system. The contract has no set-aside designation and is for the service and maintenance of this specialized scientific equipment used by the FDA. Bruker Biospin Corp has a history of providing NMR systems, upgrades, and support services...
The Department of Health and Human Services Food and Drug Administration awarded a $879,190.00 firm fixed price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to upgrade the agency's 500 and 700 MHz nuclear magnetic resonance (NMR) spectrometers. The contract, which does not have a set-aside designation, will provide new equipment, including a new cryoprobe, backup room temperature probe, and automated sample changers, to improve the sensitivity and...
The Department of Health and Human Services Food and Drug Administration awarded a $677,948.68 firm fixed price purchase order to Bruker Biospin Corp. to deliver a 400 MHz Nuclear Magnetic Resonance Spectrometer with solid and liquid probes. The solicitation sought this high-resolution NMR equipment to characterize pharmaceutical ingredients, drugs, and excipients in both liquid and solid states at the agency's Silver Spring, Maryland location. Installation, training, and maintenance services...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and equipment, for the delivery of a Cryo Probe for Nuclear Magnetic Resonance (NMR) analysis. The contract has a potential value of $187,725.00 and a completion date of December 31, 2020. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support...
This is a firm fixed-price purchase order awarded by the Department of the Army Test and Evaluation Command to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to provide a nuclear magnetic resonance (NMR) spectrometer. The potential value of the contract is $1,771,906.00, and the period of performance ends on October 31, 2019. This award does not have a set-aside designation. Bruker Biospin Corp is a subsidiary of the Bruker Corporation, which provides specialized...
Bruker Biospin Corp, a manufacturer of scientific instruments, was awarded a firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration for $1,609,000. The contract calls for Bruker Biospin Corp to provide a 600 MHz Bruker nuclear magnetic resonance spectrometer to the agency's facility in Billerica, Massachusetts by December 31, 2022. No set-aside designation was used for this procurement. Bruker Corporation is the parent company of Bruker...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, in the amount of $238,161.00. The contract is for the delivery of a cryogenically-cooled 13C direct detect probe and 3 years of preventative maintenance for an existing Bruker nuclear magnetic resonance (NMR) spectrometry system. There was no set-aside designation for this award. The original...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Bruker Biospin Corp, a manufacturer of scientific instruments and equipment. The contract is for nuclear magnetic resonance (NMR) service and support, with a total ceiling value of $85,082.40 and a period of performance through October 31, 2018. The contract does not have a set-aside designation. Bruker Biospin Corp, headquartered in Billerica, Massachusetts,...
This federal contract award, valued at $97,136.00, was issued by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for upgrades and additional imaging equipment for an existing Bruker BioSpec 4.7 T 40 cm bore system with an Avance III console magnetic resonance imaging (MRI) system. The contract does not have a set-aside designation, indicating it was competitively awarded. Bruker Biospin Corp has extensive experience providing specialized...